Article

Studying the impact of topical steroids on ptosis

Author(s):

Why instillation of topical corticosteroids may be associated with greater ptosis and higher rate of failed ptosis repair

Studying the impact of topical steroids on ptosis

Scientists who compared the degree of ptosis and the risk of failed ptosis repair surgery among patients with and without a history of topical corticosteroid use found that instillation of topical corticosteroids was associated with more severe presenting ptosis and increased rates of failed ptosis repair surgery, according to Christopher Dermarkarian, MD, from the Department of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, Houston.

Dermarkarian and his colleagues conducted a retrospective, case-controlled study that looked at topical corticosteroid use by patients with ptosis who underwent external levator advancement/resection or Müller muscle conjunctival resection.

All patients had a minimal follow-up postoperatively of 3 months. The analyses of the surgical outcomes were compared between patients who used and did not use topical corticosteroids.

Findings

A total of 240 patients (406 eyelids) were included in the study; of those, 36 patients (44 eyelids) had used topical corticosteroids.

The findings, reported in Ophthalmic Plastic and Reconstructive Surgery, differed significantly between patients who used and did not use topical corticosteroids.

The respective mean preoperative margin reflex distances were 0.20 mm and 0.58 mm (p = 0.01); the mean preoperative levator function values were 9.78 mm and 10.38 mm (p = 0.02); and the rates of failed ptosis repair surgeries were 30% and 16% (odds ratio [OR], 2.25; 95% confidence interval [CI], 1.10–4.55; p = 0.03).

The rates of recurrences/surgical type for external levator advancement/resection were 11 of 27 (41%) and 48 of 266 (18%) (OR, 3.12, CI, 1.36–7.15 0; p = 0.01) and for Müller muscle conjunctival resection were 2 of 17 (12%) and 9 of 96 (9%) (OR, 1.29, CI, 0.25–6.56; p = 0.76), the investigators reported.

“Topical corticosteroid use is associated with more severe presenting ptosis and increased rates of ptosis repair failure. Compared to Müller muscle conjunctival resection, a significantly higher rate of ptosis repair surgery failed in patients undergoing external levator advancement/resection,” they concluded.

Reference
  1. Dermarkarian CR, Williams KJ, Sweeney AR, et al. Topical corticosteroid use associated with increased degree of ptosis and rate of ptosis repair failure. Ophthalmic Plast Reconstr Surg. 2021; 37:33-37; doi: 10.1097/IOP.0000000000001671

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.